![](https://news.europawire.eu/wp-content/uploads/2024/07/Merck-and-GTRI-Collaborate-on-Advanced-Gene-Therapy-Production-for-Parkinsons-Disease-scaled-e1721816856384-144x144.jpg)
(IN BRIEF) Merck has signed an MoU with Gene Therapy Research Institution Co., Ltd. (GTRI) to support the production of gene therapy for Parkinson’s Disease using Merck’s Sf-RVN® Insect Cell Line platform. This collaboration aims to enhance the manufacturing process … Read the full press release